Affirm® Contrast Biopsy Software enables clinicians to target and obtain tissue samples from lesions identified in contrast mammography. It is an optional software license for Selenia® Dimensions® and 3Dimensions™ systems for use with I-View® enhanced mammography biopsy software and the AFFIRM® breast biopsy system.
Affirm Contrast Biopsy Software enables targeting and obtaining tissue samples from lesions identified in previous CEM examinations where a correlate cannot be found using tomosynthesis or ultrasound.
During a contrast-enhanced mammogram after iodine injection, lesions are localized with a scout view and 15-degree images.
Patients prefer CEM procedures over BMRI for reasons such as faster procedure time, greater comfort, lower anxiety, and lower noise levels.
Keep contrast examinations in the mammography package, resulting in cost savings compared to using BMRI.2 Contrast diagnostic examinations and biopsies use familiar mammography and biopsy procedures, benefiting both providers and patients.
Hologic’s powerful contrast mammography and biopsy solutions, including the AFFIRM® Upright Biopsy System, I-View® 2.0 Enhanced Mammography Software, and Affirm® Contrast Biopsy Software, provide smart tools for confidently guiding the clinical pathway from screening to diagnosis and biopsy.
This website uses cookies to enhance your experience. Some are essential for site functionality, while others help us analyze and improve your usage experience. Please review your options and make your choice.
If you are under 16 years old, please ensure that you have received consent from your parent or guardian for any non-essential cookies.
Your privacy is important to us. You can adjust your cookie settings at any time. For more information about how we use data, please read our privacy policy. You may change your preferences at any time by clicking on the settings button below.
Note that if you choose to disable some types of cookies, it may impact your experience of the site and the services we are able to offer.
Some required resources have been blocked, which can affect third-party services and may cause the site to not function properly.
This website uses cookies to enhance your browsing experience and ensure the site functions properly. By continuing to use this site, you acknowledge and accept our use of cookies.